These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16224501)

  • 1. Capturing data on medicines usage: the potential of community pharmacy databases.
    Ryan K; Norris P; Becket G
    N Z Med J; 2005 Oct; 118(1223):U1677. PubMed ID: 16224501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Equity in Prescription Medicines Use Study: using community pharmacy databases to study medicines utilisation.
    Horsburgh S; Norris P; Becket G; Crampton P; Arroll B; Cumming J; Herbison P; Sides G
    J Biomed Inform; 2010 Dec; 43(6):982-7. PubMed ID: 20709187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linking community pharmacy dispensing data to prescribing data of general practitioners.
    Florentinus SR; Souverein PC; Griens FA; Groenewegen PP; Leufkens HG; Heerdink ER
    BMC Med Inform Decis Mak; 2006 Apr; 6():18. PubMed ID: 16584557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse pharmaceutical payment incentives and providers' behaviour: the emergence of GP-owned gateway pharmacies in Taiwan.
    Lee YC; Huang KH; Huang YT
    Health Policy Plan; 2007 Nov; 22(6):427-35. PubMed ID: 17901065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical care in community pharmacies: practice and research in Denmark.
    Herborg H; Sørensen EW; Frøkjaer B
    Ann Pharmacother; 2007 Apr; 41(4):681-9. PubMed ID: 17389660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geographic Information System mapping as a tool to assess nonresponse bias in survey research.
    Hansen RA; Henley AC; Brouwer ES; Oraefo AN; Roth MT
    Res Social Adm Pharm; 2007 Sep; 3(3):249-64. PubMed ID: 17945157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE; Siracuse MV; Garis RI
    Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of a community pharmacy-operated national drug information call center in Finland.
    Pohjanoksa-Mäntylä MK; Antila J; Eerikäinen S; Enäkoski M; Hannuksela O; Pietilä K; Airaksinen M
    Res Social Adm Pharm; 2008 Jun; 4(2):144-52. PubMed ID: 18555967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to estimate the population that is covered by community pharmacies? An evaluation of two methods using drug utilisation information.
    Schirm E; Monster TB; de Vries R; van den Berg PB; de Jong-van den Berg LT; Tobi H
    Pharmacoepidemiol Drug Saf; 2004 Mar; 13(3):173-9. PubMed ID: 15072117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of drug-interaction alerts in community pharmacies.
    Indermitte J; Beutler M; Bruppacher R; Meier CR; Hersberger KE
    J Clin Pharm Ther; 2007 Apr; 32(2):133-42. PubMed ID: 17381663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of local competition on the willingness of community pharmacies to supply medication therapy management services.
    Brooks JM; Klepser DG; Urmie JM; Farris KB; Doucette WR
    J Health Hum Serv Adm; 2007; 30(1):4-27. PubMed ID: 17557694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacovigilance of over-the-counter products based in community pharmacy: methodological issues from pilot work conducted in Hampshire and Grampian, UK.
    Layton D; Sinclair HK; Bond CM; Hannaford PC; Shakir SA
    Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):503-13. PubMed ID: 12426936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Information systems for the analysis of drug prescriptions in Spain.
    Ferrando MC
    Ann Ist Super Sanita; 1991; 27(2):213-6. PubMed ID: 1755573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of perceived service quality and price competitiveness on consumer patronage of and intentions towards community pharmacies.
    Carter SR; Ahmed AM; Schneider CR
    Res Social Adm Pharm; 2023 May; 19(5):717-727. PubMed ID: 36806385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of the uptake of medicines use reviews (MURs) by community pharmacies in England: a multi-method study.
    Bradley F; Wagner AC; Elvey R; Noyce PR; Ashcroft DM
    Health Policy; 2008 Dec; 88(2-3):258-68. PubMed ID: 18468713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating Australia's National Medicines Policy using geographical mapping.
    Roughead EE; Monteith GR; Harvey KJ; Tett SE
    Intern Med J; 2002 Mar; 32(3):66-71. PubMed ID: 11885845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective evaluation of home medicines review by pharmacists in older Australian patients using the medication appropriateness index.
    Castelino RL; Bajorek BV; Chen TF
    Ann Pharmacother; 2010 Dec; 44(12):1922-9. PubMed ID: 21119095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Issues with prescribed medications in Aboriginal communities: Aboriginal health workers' perspectives.
    Hamrosi K; Taylor SJ; Aslani P
    Rural Remote Health; 2006; 6(2):557. PubMed ID: 16683907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical care in community pharmacies: practice and research in the US.
    Christensen DB; Farris KB
    Ann Pharmacother; 2006; 40(7-8):1400-6. PubMed ID: 16868221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey of drug-related problems identified by community pharmacies.
    Hämmerlein A; Griese N; Schulz M
    Ann Pharmacother; 2007 Nov; 41(11):1825-32. PubMed ID: 17925500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.